BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15983026)

  • 1. In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
    Giacometti A; Cirioni O; Kamysz W; Silvestri C; Del Prete MS; Licci A; D'Amato G; Lukasiak J; Scalise G
    J Antimicrob Chemother; 2005 Aug; 56(2):410-2. PubMed ID: 15983026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics.
    Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Del Prete MS; Licci A; Lukasiak J; Scalise G
    J Antimicrob Chemother; 2005 Feb; 55(2):272-4. PubMed ID: 15649993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection.
    Giacometti A; Cirioni O; Kamysz W; Silvestri C; Licci A; Riva A; Łukasiak J; Scalise G
    Peptides; 2005 Nov; 26(11):2111-6. PubMed ID: 16269345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections.
    Giacometti A; Cirioni O; Kamysz W; Silvestri C; Del Prete MS; Licci A; D'Amato G; Łukasiak J; Scalise G
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2507-9. PubMed ID: 15917557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients.
    Giacometti A; Cirioni O; Kamysz W; Silvestri C; Licci A; D'Amato G; Nadolski P; Riva A; Lukasiak J; Scalise G
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3933-6. PubMed ID: 16127075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of polycationic peptides alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
    Giacometti A; Cirioni O; Ancarani F; Del Prete MS; Fortuna M; Scalise G
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2093-6. PubMed ID: 10428947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
    Berghaus LJ; Giguère S; Guldbech K
    Vet Microbiol; 2013 Oct; 166(3-4):670-5. PubMed ID: 23915992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi.
    Giguère S; Lee EA; Guldbech KM; Berghaus LJ
    Vet Microbiol; 2012 Nov; 160(1-2):207-13. PubMed ID: 22704561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
    Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Licci A; Nadolski P; Riva A; Lukasiak J; Scalise G
    Int J Antimicrob Agents; 2005 Sep; 26(3):235-40. PubMed ID: 16122911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial preservative effectiveness of natural peptide antibiotics.
    Kamysz W; Turecka K
    Acta Pol Pharm; 2005; 62(5):341-4. PubMed ID: 16459482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
    Mascellino MT; Iona E; Ponzo R; Mastroianni CM; Delia S
    Int J Clin Pharmacol Res; 1994; 14(5-6):157-63. PubMed ID: 7672872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MICs of 32 antimicrobial agents for Rhodococcus equi isolates of animal origin.
    Riesenberg A; Feßler AT; Erol E; Prenger-Berninghoff E; Stamm I; Böse R; Heusinger A; Klarmann D; Werckenthin C; Schwarz S
    J Antimicrob Chemother; 2014 Apr; 69(4):1045-9. PubMed ID: 24275117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
    Giacometti A; Cirioni O; Riva A; Kamysz W; Silvestri C; Nadolski P; Della Vittoria A; Łukasiak J; Scalise G
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1494-6. PubMed ID: 17220421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
    Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G
    Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics.
    Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Simona Del Prete M; Lukasiak J; Scalise G
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):197-200. PubMed ID: 15246510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
    Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
    Boyen F; Pasmans F; Haesebrouck F
    Vet Rec; 2011 Jan; 168(4):101a. PubMed ID: 21257598
    [No Abstract]   [Full Text] [Related]  

  • 18. In-vitro antimicrobial susceptibility of Rhodococcus equi.
    Nordmann P; Ronco E
    J Antimicrob Chemother; 1992 Apr; 29(4):383-93. PubMed ID: 1607327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis.
    Petersen PJ; Labthavikul P; Jones CH; Bradford PA
    J Antimicrob Chemother; 2006 Mar; 57(3):573-6. PubMed ID: 16431863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characterization of Rhodococcus equi isolates from horse and man].
    Fuhrmann C; Lämmler C
    Berl Munch Tierarztl Wochenschr; 1997 Feb; 110(2):54-9. PubMed ID: 9139629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.